ES-8891, an orally active inhibitor of human renin.
- 1 June 1990
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 15 (6_pt_2), 909-913
- https://doi.org/10.1161/01.hyp.15.6.909
Abstract
A newly synthesized orally active renin inhibitor, N-morpholinoacetyl-(1-naphthyl)-L-alanyl-(4-thiazolyl)-L-alanyl (3S,4S)-4-amino-3-hydroxy-5-cyclohexylpentanoyl-n-hexylamide (ES-8891), was found to be a highly potent competitive inhibitor of human renin with an inhibition constant of 1.1 nM. This inhibitor was also active against monkey renin, although there was less inhibition of renin in pig, rabbit, and rat. ES-8891 did not inhibit cathepsin D, pepsin, trypsin, chymotrypsin, angiotensin converting enzyme, and urinary kallikrein at a concentration of 10(-5) M. A single oral administration of ES-8891 (10 or 30 mg/kg) to conscious, sodium-depleted marmosets caused a dose-related decrease in plasma renin activity and blood pressure. ES-8891 (30 mg/kg) produced an 80% inhibition of plasma renin activity, which lasted for more than 6 hours. Kidney renin messenger RNA was not significantly changed 6 hours after oral administration of ES-8891 (30 mg/kg). A single oral administration of 240 mg ES-8891 to healthy human volunteers (n = 6) produced a significant inhibition of plasma renin activity (75% inhibition at 0.5 and 1 hour, 50% inhibition at 2 hours) with a good correlation of plasma levels of ES-8891. There were no significant changes in blood pressure or heart rate, and no adverse effects were observed. These results suggest that ES-8891 is an orally active human renin inhibitor that may be clinically useful.Keywords
This publication has 20 references indexed in Scilit:
- Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.Hypertension, 1989
- Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans.Hypertension, 1989
- A novel nonpeptidic, orally active renin inhibitorBiochemical and Biophysical Research Communications, 1989
- A highly potent and long-acting oral inhibitor of human renin.Hypertension, 1988
- An orally active inhibitor of renin.Hypertension, 1986
- Statine-containing dipeptide and tripeptide inhibitors of human renin.Hypertension, 1986
- A Study of the Renin Inhibitor H142 in ManJournal Of Hypertension, 1985
- Nonproportional changes in plasma renin concentration, renal renin content, and rat renin messenger RNA.Hypertension, 1985
- Effects of a specific and long-acting renin inhibitor in the marmoset.Hypertension, 1985
- The ovalbumin gene family: Hormonal control of X and Y gene transcription and mRNA accumulationCell, 1981